- title: "VISION-TDM"
  path: "#"
  description: "Measuring whether therapeutic drug monitoring of ibrutinib and venetoclax reduces toxicity and improves efficacy in patients with chronic lymphocytic leukaemia. Funded by the Danish Cancer Society."
  start: 2024

- title: "SAMSON-2"
  path: "#"
  description: "Multicenter N-of-1 trial testing whether SLCO1B1 genotype predicts statin-associated muscle symptoms. Funded by the Capital Region of Denmark."
  start: 2024

- title: "Pharmacogenomics in the Capital Region"
  path: "#"
  description: "Implementing pre-emptive pharmacogenetic testing at Rigshospitalet for DPYD, TPMT/NUDT15, CYP2C19, and CYP2D6 to guide prescribing before treatment initiation."
  start: 2025
